Medicine and Dentistry
Lung
100%
Neoplasm
87%
Lung Transplantation
49%
Allograft
42%
Lung Graft Rejection
32%
Immunohistochemistry
28%
Morphology
26%
Gene Transfer
25%
Disease
24%
Acute Graft Rejection
24%
Diagnosis
24%
Differential Diagnosis
21%
Carcinoma
20%
Cancer Growth Factor
20%
Cancer
16%
Fibrinogen
16%
Surgery
15%
Interleukin 10
14%
Adenocarcinoma
14%
Colorectal Carcinoma
14%
Non Small Cell Lung Cancer
14%
Lymphocytic Infiltration
13%
Genetic Transfection
13%
Metastatic Carcinoma
13%
Visceral Pleura
13%
Infection
12%
T Cell
12%
Lymphatic Tissue
12%
Pathologist
12%
Computer Assisted Tomography
12%
Sarcomatoid Carcinoma
12%
Plasma Cell Granuloma
12%
Subcutaneous Tissue
11%
Adenoviridae
11%
Sarcoidosis
11%
Melanoma
11%
Reperfusion Injury
11%
Immunoreactivity
11%
Graft Rejection
11%
Malignant Neoplasm
11%
Lung Adenocarcinoma
11%
Emphysema
11%
Magnetic Resonance Imaging
9%
Protein P53
9%
Neuroendocrine Tumor
9%
Biopsy Technique
9%
Clear Cell Carcinoma
9%
Inducible Nitric Oxide Synthase
9%
Injury
8%
Connective Tissue Cancer
8%
Keyphrases
Lung
75%
Lung Transplantation
50%
Tumor
38%
Lung Allograft
34%
Lung Allograft Rejection
31%
Gene Transfer
24%
Transforming Growth Factor-β
24%
Rat Lung
24%
Differential Diagnosis
23%
Neoplasms
21%
Transplantation
21%
Ischemia-reperfusion Injury
20%
Acute Rejection
20%
Allograft
18%
Immunohistochemistry
17%
T Cells
16%
Histologic
16%
Loss of Heterozygosity
15%
Carcinoma
15%
Bronchus-associated Lymphoid Tissue
15%
Non-small Cell Lung Cancer (NSCLC)
14%
Interleukin-10
13%
Lymphocyte Infiltration
13%
Immunostain
13%
Pathologist
13%
Breast Carcinoma
12%
Inducible Nitric Oxide Synthase
12%
Pleura
12%
Sarcomatoid Carcinoma
12%
Allograft Acceptance
11%
Immunophenotyping
11%
Breast Cancer
11%
Morphological Characteristics
11%
Immunoreactivity
11%
Inflammatory Pseudotumor
11%
Cutaneous Lymphoid
11%
Computed Tomography
10%
Biopsy Specimen
10%
Malignancy
10%
Histopathological Features
10%
Subcutis
10%
Magnetic Resonance Imaging
9%
Ductal Carcinoma in Situ
9%
Quantitative PCR
9%
Clear Cell Tumor
9%
Tolerance Induction
9%
Paraffin Section
9%
Adenocarcinoma
9%
Neuroendocrine Carcinoma
8%
Plasmid
8%